【作者】 傅熙玲；

【导师】 孙为豪；

【作者基本信息】 东南大学 ， 内科学， 2005， 硕士

【摘要】 目的:评价左卡尼汀联合甘利欣注射液治疗非酒精性脂肪性肝病的临床疗效。方法:100例非酒精性脂肪性肝病患者随机分为两组,治疗组62例,对照组38例。治疗组给予左卡尼汀1 000 mg和甘利欣150 mg静脉滴注,对照组甘利欣150 mg,每天1次连续4周。治疗结束后复查B超、肝功能和血脂水平。结果:治疗后两组病例肝功能酶学指标均较治疗前显著性下降(P < 0.01),但两组间无显著性差异(P > 0.05)。治疗组血清甘油三酯(TG)和胆固醇(TC)水平分别为(2.50±1.44)和(4.98±2.12)mmol/L,较治疗前显著性下降(P < 0.01);而对照组TG和TC水平治疗前、后无显著性差异(P > 0.05)。治疗组B超检查脂肪肝声像图消退率58.1%,明显优于对照组的28.9%(P < 0.05)。治疗组血脂改善总有效率96.7%,显著高于对照组的44.7% (P < 0.05)。结论:左卡尼汀联合甘利欣治疗非酒精性脂肪性肝病,对改善肝功能和降低血脂有确切疗效。更多还原

【Abstract】 Objective: Fatty liver is a condition of hepatic steatosis caused by many risk factors and may progress to liver fibrosis and cirrhosis. Thus, treatment should be given for patients who are at risk of developing severe liver disease. However, the management of fatty liver is less than certain. The aim of this prospective study was to evaluate the therapeutic effects of L-Carnitine combined with Glycyrrhiazte diammonium in the treatment of nonalcoholic fatty liver disease (NAFLD).Methods: A total of 100 patients with NAFLD demonstrated by color Doppler ultrasound examination were randomized divided into two groups. The treatment group (n = 62) was intravenously given L-Carnitine 1 000 mg and Glycyrrhiazte diammonium 150 mg once daily for 4 weeks. The control group (n = 38) was treated with Glycyrrhiazte diammonium only. After 4 weeks of treatment, serum transaminase and lipid levels, and liver ultrasonography were repeated.Results: The serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were significantly decreased after treatment with Glycyrrhiazte diammonium combined with or without L-Carnitine, but there were no significant differences between the two groups. Serum triglyceride (TG) and total cholesterol (TC) levels were (2.50±1.44) and (4.98±2.12) mmol/L respectively in the patients after treatment with L-Carnitine and Glycyrrhiazte diammonium, which were significantly lower than those prior to treatment (P < 0.01). No significant changes in serum levels of TG and TC were observed before and after treatment in the control group. Ultrasonography showed resolution of fatty liver in 58.1% of patients treated with L-Carnitine and Glycyrrhiazte diammonium, which were significantly higher than 28.9% in the control group (P < 0.05). The total effective rate for decreasing serum lipid level in treatment group was 96.7%, which was significantly higher than 44.7% in control group.Conclusions: L-Carnitine in combination with Glycyrrhiazte diammonium has a reliable therapeutic effect on NAFLD in improving liver function and decreasing serum lipid level.更多还原